匹布伦他韦

匹布伦他韦（CAS 1353900-92-1）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

Indicated for the treatment of adult patients with acute and chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is also indicated for the treatment of adult patients with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.Breast Feeding; Lactation; Milk, Human; Antiviral Agents; NS5A Inhibitors

同义词与商品名

Pibrentasvir; 1353900-92-1; ABT-530; A-1325912.0; 2WU922TK3L; DTXSID601027946; pibrentasvirum; RefChem:863096; DTXCID501513514; 829-351-5; Pibrentasvir [USAN]; ABT 530; Abt530; D10816; Pibrentasvir (ABT-530); C57H65F5N10O8

GHS 危害分类

Reported hazard statements	H315 (100%), H319 (100%), H335 (100%), H413 (100%)

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

公开数据库对它的描述

Pibrentasvir · CAS 1353900-92-1 · C57H65F5N10O8. UNII 2WU922TK3L. Solubility: <0.1 mg/mL.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。